Effects of hypervolemia and hypertension on regional cerebral blood flow, intracranial pressure, and brain tissue oxygenation after subarachnoid hemorrhage

Critical Care Medicine

Volumn 35, Issue 8, 2007, Pages 1844-1851

  Muench, Elke ^a,h   Horn, Peter ^b   Bauhuf, Christian ^c   Roth, Harry ^d   Philipps, Mark ^e   Hermann, Peter ^f   Quintel, Michael ^f   Schmiedek, Peter ^a   Vajkoczy, Peter ^g  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF HAMBURG   (Germany)

^c UNIVERSITY OF REGENSBURG   (Germany)

^d Department of Anesthesiology and Intensive Care   (Germany)

^e JOHANNES GUTENBERG UNIVERSITY   (Germany)

^f UNIVERSITY OF GÖTTINGEN   (Germany)

^g CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^h UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Hemodilution; Hypertension; Subarachnoid hemorrhage; Triple H therapy; Vasospasm

Indexed keywords

HYPERTENSIVE FACTOR;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VOLUME; BRAIN BLOOD FLOW; BRAIN PERFUSION; BRAIN TISSUE; BRAIN VASOSPASM; CENTRAL VENOUS PRESSURE; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID DRAINAGE; CLINICAL ARTICLE; COLLOID; CONTROLLED STUDY; CRYSTALLOID; FEMALE; HEART OUTPUT; HEMODILUTION; HUMAN; HYPERTENSION; HYPERVOLEMIA; INTRACRANIAL PRESSURE; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; OXYGENATION; PRIORITY JOURNAL; SUBARACHNOID HEMORRHAGE; TREATMENT OUTCOME;

ADULT; AGED; ANIMALS; CEREBROVASCULAR CIRCULATION; FEMALE; HEMODILUTION; HETASTARCH; HUMANS; INTRACRANIAL PRESSURE; ISOTONIC SOLUTIONS; MALE; MIDDLE AGED; OXYGEN; PLASMA SUBSTITUTES; SUBARACHNOID HEMORRHAGE; SWINE; VASOCONSTRICTOR AGENTS; VASOSPASM, INTRACRANIAL;

EID: 34547681749     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000275392.08410.DD     Document Type: Article

References (52)

1. Baldwin ME, Macdonald RL, Huo D, et al: Early vasospasm on admission angiography in patients with aneurysmal subarachnoid hemorrhage is a predictor for in-hospital complications and poor outcome. Stroke 2004; 35:2506-2511
2. Claassen J, Bernardini GL, Kreiter K, et al: Effect of cisternal and ventricular blood on risk of delayed cerebral ischemia after subarachnoid hemorrhage: The Fisher scale revisited. Stroke 2001; 32:2012-2020
3. Solenski NJ, Haley EC Jr, Kassell NF, et al: Medical complications of aneurysmal subarachnoid hemorrhage: A report of the multicenter, cooperative aneurysm study. Participants of the Multicenter Cooperative Aneurysm Study. Crit Care Med 1995; 23:1007-1017
4. Mendelow AD, Dharker S, Patterson J, et al: The dopamine withdrawal test following surgery for intracranial aneurysms. J Neurol Neurosurg Psychiatry 1986; 49:35-38
5. Meyer CH, Lowe D, Meyer M, et al: Progressive change in cerebral blood flow during the first three weeks after subarachnoid hemorrhage. Neurosurgery 1983; 12:58-76
6. Muizelaar JP, Becker DP: Induced hypertension for the treatment of cerebral ischemia after subarachnoid hemorrhage. Direct effect on cerebral blood flow. Surg Neurol 1986; 25:317-325
7. Origitano TC, Wascher TM, Reichman OH, et al: Sustained increased cerebral blood flow with prophylactic hypertensive hypervolemic hemodilution ("triple-H" therapy) after subarachnoid hemorrhage. Neurosurgery 1990; 27:729-739
8. Critchley GR, Bell BA: Acute cerebral tissue oxygenation changes following experimental subarachnoid hemorrhage. Neurol Res 2003; 25:451-456
9. Prunell GF, Mathiesen T, Svendgaard NA: Experimental subarachnoid hemorrhage: Cerebral blood flow and brain metabolism during the acute phase in three different models in the rat. Neurosurgery 2004; 54:426-436
10. Fandino J, Kaku Y, Schuknecht B, et al: Improvement of cerebral oxygenation patterns and metabolic validation of superselective intraarterial infusion of papaverine for the treatment of cerebral vasospasm. J Neurosurg 1998; 89:93-100
11. Schneider GH, von Helden A, Lanksch WR, et al: Continuous monitoring of jugular bulb oxygen saturation in comatose patients - Therapeutic implications. Acta Neurochir (Wien) 1995; 134:71-75
12. Pritz MB, Giannotta SL, Kindt GW, et al: Treatment of patients with neurological deficits associated with cerebral vasospasm by intravascular volume expansion. Neurosurgery 1978; 3:364-368
13. Awad IA, Carter LP, Spetzler RF, et al: Clinical vasospasm after subarachnoid hemorrhage: Response to hypervolemic hemodilution and arterial hypertension. Stroke 1987; 18:365-372
14. Kassell NF, Peerless SJ, Durward QJ, et al: Treatment of ischemic deficits from vasospasm with intravascular volume expansion and induced arterial hypertension. Neurosurgery 1982; 11:337-343
15. Levy ML, Giannotta SL: Cardiac performance indices during hypervolemic therapy for cerebral vasospasm. J Neurosurg 1991; 75:27-31
16. Raabe A, Beck J, Keller M, et al: Relative importance of hypertension compared with hypervolemia for increasing cerebral oxygenation in patients with cerebral vasospasm after subarachnoid hemorrhage. J Neurosurg 2005; 103:974-981
17. Joseph M, Ziadi S, Nates J, et al: Increases in cardiac output can reverse flow deficits from vasospasm independent of blood pressure: A study using xenon computed tomographic measurement of cerebral blood flow. Neurosurgery 2003; 53:1044-1051
18. Muench E, Bauhuf C, Roth H, et al: Effects of positive end-expiratory pressure on regional cerebral blood flow, intracranial pressure, and brain tissue oxygenation. Crit Care Med 2005; 33:2367-2372
19. Hunt WE, Hess RM: Surgical risk as related to time of intervention in the repair of intracranial aneurysms. J Neurosurg 1968; 28:14-20
20. Fisher CM, Kistler JP, Davis JM: Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery 1980; 6:1-9
21. Vajkoczy P, Roth H, Horn P, et al: Continuous monitoring of regional cerebral blood flow: Experimental and clinical validation of a novel thermal diffusion microprobe. J Neurosurg 2000; 93:265-274
22. Kiening KL, Hartl R, Unterberg AW, et al: Brain tissue pO2-monitoring in comatose patients: Implications for therapy. Neurol Res 1997; 19:233-240
23. Vajkoczy P, Horn P, Thome C, et al: Regional cerebral blood flow monitoring in the diagnosis of delayed ischemia following aneurysmal subarachnoid hemorrhage. J Neurosurg 2003; 98:1227-1234
24. Dirnagl U, Pulsinelli W: Autoregulation of cerebral blood flow in experimental focal brain ischemia. J Cereb Blood Flow Metab 1990; 10:327-336
25. Kosnik EJ, Hunt WE: Postoperative hypertension in the management of patients with intracranial arterial aneurysms. J Neurosurg 1976; 45:148-154
26. Shimoda M, Oda S, Tsugane R, et al: Intracranial complications of hypervolemic therapy in patients with a delayed ischemic deficit attributed to vasospasm. J Neurosurg 1993; 78:423-429
27. Segal E, Greenlee JD, Hata SJ, et al: Monitoring intravascular volumes to direct hypertensive, hypervolemic therapy in a patient with vasospasm. J Neurosurg Anesthesiol 2004; 16:296-298
28. Darby JM, Yonas H, Marks EC, et al: Acute cerebral blood flow response to dopamine-induced hypertension after subarachnoid hemorrhage. J Neurosurg 1994; 80:857-864
29. Touho H, Karasawa J, Ohnishi H, et al: Evaluation of therapeutically induced hypertension in patients with delayed cerebral vasospasm by xenon-enhanced computed tomography. Neurol Med Chir (Tokyo) 1992; 32:671-678
30. Wood JH, Simeone FA, Kron RE, et al: Experimental hypervolemic hemodilution: Physiological correlations of cortical blood flow, cardiac output, and intracranial pressure with fresh blood viscosity and plasma volume. Neurosurgery 1984; 14:709-723
31. Wood JH, Fleischer AS: Observations during hypervolemic hemodilution of patients with acute focal cerebral ischemia. JAMA 1982; 248:2999-2304
32. Archer DP, Shaw DA, Leblanc RL, et al: Haemodynamic considerations in the management of patients with subarachnoid haemorrhage. Can J Anaesth 1991; 38:454-470
33. Mori K, Arai H, Nakajima K, et al: Hemorheological and hemodynamic analysis of hypervolemic hemodilution therapy for cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Stroke 1995; 26: 1620 -1626
34. Matsui T, Asano T: The hemodynamic effects of prolonged albumin administration in beagle dogs exposed to experimental subarachnoid hemorrhage. Neurosurgery 1993; 32:79-83
35. Tranmer BI, Keller TS, Kindt GW, et al: Loss of cerebral regulation during cardiac output variations in focal cerebral ischemia. J Neurosurg 1992; 77:253-259
36. Solomon RA, Fink ME, Lennihan L: Prophylactic volume expansion therapy for the prevention of delayed cerebral ischemia after early aneurysm surgery. Results of a preliminary trial. Arch Neurol 1988; 45:325-332
37. Solomon RA, Fink ME, Lennihan L: Early aneurysm surgery and prophylactic hypervolemic hypertensive therapy for the treatment of aneurysmal subarachnoid hemorrhage. Neurosurgery 1988; 23:699-704
38. Medlock MD, Dulebohn SC, Elwood PW: Prophylactic hypervolemia without calcium channel blockers in early aneurysm surgery. Neurosurgery 1992; 30:12-16
39. Lennihan L, Mayer SA, Fink ME, et al: Effect of hypervolemic therapy on cerebral blood flow after subarachnoid hemorrhage: A randomized controlled trial. Stroke 2000; 31:383-391
40. Yamakami I, Isobe K, Yamaura A: Effects of intravascular volume expansion on cerebral blood flow in patients with ruptured cerebral aneurysms. Neurosurgery 1987; 21:303-309
41. Ekelund A, Reinstrup P, Ryding E, et al: Effects of iso- and hypervolemic hemodilution on regional cerebral blood flow and oxygen delivery for patients with vasospasm after aneurysmal subarachnoid hemorrhage. Acta Neurochir (Wien) 2002; 144:703-712
42. Bendjelid K, Romand JA: Fluid responsiveness in mechanically ventilated patients: A review of indices used in intensive care. Intensive Care Med 2003; 29:352-360
43. Kiyohara Y, Fujishima M, Ishitsuka T, et al: Effects of hematocrit on brain metabolism in experimentally induced cerebral ischemia in spontaneously hypertensive rats (SHR). Stroke 1985; 16:835-840
44. Stone HO, Thompson HK Jr, Schmidt-Nielsen K: Influence of erythrocytes on blood viscosity. Am J Physiol 1968; 214:913-918
45. Tohgi H, Yamanouchi H, Murakami M, et al: Importance of the hematocrit as a risk factor in cerebral infarction. Stroke 1978; 9:369-374
46. Tu YK, Heros RC, Candia G, et al: Isovolemic hemodilution in experimental focal cerebral ischemia. Part 1: Effects on hemodynamics, hemorheology, and intracranial pressure. J Neurosurg 1988; 69:72-81
47. Tu YK, Heros RC, Karacostas D, et al: Isovolemic hemodilution in experimental focal cerebral ischemia. Part 2: Effects on regional cerebral blood flow and size of infarction. J Neurosurg 1988; 69:82-91
48. Janjua N, Mayer SA: Cerebral vasospasm after subarachnoid hemorrhage. Curr Opin Crit Care 2003; 9:113-119
49. Conrad SA, Dietrich KA, Hebert CA, et al: Effect of red cell transfusion on oxygen consumption following fluid resuscitation in septic shock. Circ Shock 1990; 31:419-429
50. Dietrich KA, Conrad SA, Hebert CA, et al: Cardiovascular and metabolic response to red blood cell transfusion in critically ill volume-resuscitated nonsurgical patients. Crit Care Med 1990; 18:940-944
51. Smith MJ, Stiefel MF, Magge S, et al: Packed red blood cell transfusion increases local cerebral oxygenation. Crit Care Med 2005; 33:1104-1108
52. Stiefel MF, Spiotta A, Gracias VH, et al: Reduced mortality rate in patients with severe traumatic brain injury treated with brain tissue oxygen monitoring. J Neurosurg 2005; 103:805-811